The FDA issued guidance stating that 503A compounding pharmacies had until April 22, 2025 to stop producing semaglutide injection products that were essentially copies of the commercially available drug
Mikhail Kosiborod, cardiologist and vice president for research at Saint Lukes Mid America Heart Institute, Kansas City, Missouri, who led the trial
There is no evidence that semaglutide reduces antibiotic efficacy for any common indication
Reserving your bed for sleep and sex only trains your brain to associate that space with rest rather than work, scrolling, or watching television
Which medication causes fewer side effects
Semaglutide is available as both an injectable and an oral pill, effectively mimicking the GLP-1 hormone to suppress appetite and promote sustained weight loss